Dr. Fillit on Eli Lilly’s Alzheimer’s drug: Really having breakthroughs & success for the first time

Dr. Howard Fillit, Alzheimer’s Drug Discovery Foundation co-founder and chief science officer, joins ‘Squawk Box’ to discuss news of FDA panel’s approval of Eli Lilly’s Alzheimer’s drug Donanemab, the future of Alzheimer’s treatments, and more.